Omar Al Laham1, Gheed Abdul Khalek2, Hazar Alboushi3, Abd Al Hameed Al Mohammad4, Mohamad Almaydaani5, Alaa Alhanwt6. 1. Faculty of Medicine, Damascus University, Damascus, Syria. Electronic address: 3omar92@gmail.com. 2. Department of Surgery, Al-Mouwasat University Hospital, Damascus, Syria; Department of Surgery, Al Assad University Hospital, Damascus, Syria. Electronic address: cherryblossomsss11@gmail.com. 3. Department of Pathology, Al-Mouwasat University Hospital, Damascus, Syria; Department of Pathology, Al Assad University Hospital, Damascus, Syria. Electronic address: hazarbo94@gmail.com. 4. Department of Surgery, Al-Mouwasat University Hospital, Damascus, Syria; Department of Surgery, Al Assad University Hospital, Damascus, Syria. Electronic address: hamit.arr10@gmail.com. 5. Department of Surgery, Al-Mouwasat University Hospital, Damascus, Syria; Department of Surgery, Al Assad University Hospital, Damascus, Syria. Electronic address: Mohamedmedaane@gmail.com. 6. Department of General Surgery, Al Assad University Hospital, Damascus, Syria. Electronic address: hakem.1983@gmail.com.
Abstract
INTRODUCTION AND IMPORTANCE: Sarcomas are malignant mesenchymal-cell tumors that comprise 1 % of all adult tumors. Undifferentiated Pleomorphic Sarcoma comprises a vastly rare subtype. It mostly occurs in males in their 6th decade of life. However, their exact incidence remains poorly demarcated, especially those occurring in the scalp. Since they lack any disease-specific presentations, we should maintain high clinical suspicion when presented with similar cases. CASE PRESENTATION: Herein, we demonstrate the clinical case of a 52-year-old Middle Eastern female, who presented to the outpatient clinic complaining of a one-year history of progressively growing protuberance in her right side of the scalp. It was painful and rapidly increased in size. Presurgical radiological assessment suspected a cystic formation. Utter resection of the mass was achieved, and histopathological analysis diagnosed it as a primary Undifferentiated Pleomorphic Sarcoma. CLINICAL DISCUSSION: Meticulous surgical resection was the cornerstone treatment of our patient. Radiological imaging in addition to clinical suspicion was utilized for preoperative assessment. This patient has had a successful post-surgical recovery. She has been surveilled for 6 months so far with no evidence of tumor recurrence, metastasis, or clinical complications. CONCLUSION: It is especially rare to see a primary Undifferentiated Pleomorphic Sarcoma in any patient population. It's even rarer that it occurs in such a patient demographic. Hence, it's vital that we document cases of this rare malignancy because that would lead the way in conducting informative clinical studies which enable physicians to select the proper treatment modality.
INTRODUCTION AND IMPORTANCE: Sarcomas are malignant mesenchymal-cell tumors that comprise 1 % of all adult tumors. Undifferentiated Pleomorphic Sarcoma comprises a vastly rare subtype. It mostly occurs in males in their 6th decade of life. However, their exact incidence remains poorly demarcated, especially those occurring in the scalp. Since they lack any disease-specific presentations, we should maintain high clinical suspicion when presented with similar cases. CASE PRESENTATION: Herein, we demonstrate the clinical case of a 52-year-old Middle Eastern female, who presented to the outpatient clinic complaining of a one-year history of progressively growing protuberance in her right side of the scalp. It was painful and rapidly increased in size. Presurgical radiological assessment suspected a cystic formation. Utter resection of the mass was achieved, and histopathological analysis diagnosed it as a primary Undifferentiated Pleomorphic Sarcoma. CLINICAL DISCUSSION: Meticulous surgical resection was the cornerstone treatment of our patient. Radiological imaging in addition to clinical suspicion was utilized for preoperative assessment. This patient has had a successful post-surgical recovery. She has been surveilled for 6 months so far with no evidence of tumor recurrence, metastasis, or clinical complications. CONCLUSION: It is especially rare to see a primary Undifferentiated Pleomorphic Sarcoma in any patient population. It's even rarer that it occurs in such a patient demographic. Hence, it's vital that we document cases of this rare malignancy because that would lead the way in conducting informative clinical studies which enable physicians to select the proper treatment modality.
Authors: Jorge R Toro; Lois B Travis; Hongyu Julian Wu; Kangmin Zhu; Christopher D M Fletcher; Susan S Devesa Journal: Int J Cancer Date: 2006-12-15 Impact factor: 7.396
Authors: Sarah M Elswick; Daniel A Curiel; Peter Wu; Arya Akhavan; Vanessa E Molinar; Anita T Mohan; Frank H Sim; Jorys Martinez-Jorge; Michel Saint-Cyr Journal: J Surg Oncol Date: 2020-02-04 Impact factor: 3.454
Authors: Sean P Dineen; Christina L Roland; Rachel Feig; Caitlin May; Shouhao Zhou; Elizabeth Demicco; Ghadah Al Sannaa; Davis Ingram; Wei-Lein Wang; Vinod Ravi; Ashleigh Guadagnolo; Dina Lev; Raphael E Pollock; Kelly Hunt; Janice Cormier; Alex Lazar; Barry Feig; Keila E Torres Journal: Ann Surg Oncol Date: 2015-03-06 Impact factor: 5.344
Authors: Daniel Winchester; Julia Lehman; Tiffany Tello; Nicolette Chimato; Thomas Hocker; Sunhee Kim; Joseph Chang; Jeffrey Markey; Sue S Yom; William Ryan; Thaddeus Mully; David Hodge; Clark Otley; Sarah T Arron Journal: J Am Acad Dermatol Date: 2018-05-19 Impact factor: 11.527